Acadia Pharmaceutica (ACAD)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2016 | 09-2016 | 06-2016 | 03-2016 | 12-2015 | |
| Sales | 11,962 | 5,268 | 97 | 4 | 17 |
| Cost of Goods | 1,704 | 845 | 526 | N/A | N/A |
| Gross Profit | 10,258 | 4,423 | -429 | 4 | 17 |
| Operating Expenses | 89,193 | 77,667 | 72,020 | 50,266 | 45,582 |
| Operating Income | -78,231 | -72,399 | -71,923 | -50,262 | -45,565 |
| Other Income | 876 | 786 | 601 | 500 | 111 |
| Pre-tax Income | -77,355 | -71,613 | -71,322 | -49,762 | -45,454 |
| Net Income Continuous | -78,696 | -71,613 | -71,322 | -49,762 | -45,784 |
| Net Income | $-78,696 | $-71,613 | $-71,322 | $-49,762 | $-45,784 |
| EPS Basic Total Ops | -0.65 | -0.61 | -0.63 | -0.45 | -0.45 |
| EPS Basic Continuous Ops | -0.66 | -0.61 | -0.63 | -0.45 | -0.45 |
| EPS Diluted Total Ops | -0.65 | -0.61 | -0.63 | -0.45 | -0.45 |
| EPS Diluted Continuous Ops | -0.66 | -0.61 | -0.63 | -0.45 | -0.45 |
| EBITDA(a) | $-77,657 | $-71,421 | $-71,462 | $-50,358 | $-45,595 |